AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

ENDoscopic Assessment in Acute PANcreatitis Study (ENDOPAN Study)

Recruitingn/aAges 18 Years - anyAllJan Kochanowski University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a prospective observational cohort study designed to evaluate early upper gastrointestinal endoscopic findings in adult patients hospitalized with acute pancreatitis. The study aims to determine whether gastric and duodenal mucosal abnormalities detected during early hospitalization are associated with the severity and clinical course of acute pancreatitis. Adult patients diagnosed with acute pancreatitis according to the revised Atlanta criteria will be enrolled after providing informed consent. Upper gastrointestinal endoscopy will be performed within 24-48 hours from hospital admission. In patients with moderately severe or severe acute pancreatitis, a follow-up endoscopy may be performed before discharge. Clinical, laboratory, imaging, microbiological, and endoscopic data will be collected prospectively during the index hospitalization. The primary objective is to assess th

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older. * Diagnosis of acute pancreatitis according to the revised Atlanta criteria, defined by the presence of at least two of the following three features: typical abdominal pain consistent with acute pancreatitis; serum amylase and/or lipase activity at least three times the upper limit of normal; imaging findings consistent with acute pancreatitis. * Hospital admission due to acute pancreatitis to the study center. * Admission during the early phase of acute pancreatitis, allowing planned upper gastrointestinal endoscopy within 24-48 hours from hospital admission. * Ability to undergo diagnostic upper gastrointestinal endoscopy according to the investigator's and treating physician's assessment. * Ability to provide written informed consent before enrollment and before any study-specific procedure. Exclusion Criteria: * Age below 18 years. * Lack of written informed consent. * Inability to provide informed consent before enrollment. * Clinical condition precluding safe diagnostic upper gastrointestinal endoscopy, including hemodynamic instability, severe respiratory failure, or other unstable life-threatening condition. * Need for emergency therapeutic upper gastrointestinal endoscopy before planned study endoscopy, for example due to active upper gastrointestinal bleeding. * Known or suspected gastrointestinal perforation. * Previous gastric or duodenal surgery significantly altering upper gastrointestinal anatomy and preventing reliable assessment of gastric or duodenal mucosa. * Known advanced upper gastrointestinal malignancy affecting the stomach or duodenum. * Pregnancy. * Contraindication to upper gastrointestinal endoscopy or sedation according to the treating physician's or investigator's assessment. * Any condition that, in the investigator's opinion, would make participation unsafe or would prevent completion of study procedures.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Department of General, Oncologic and Endocrine Surgery, Regional Hospital in Kielce
Kielce, Poland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy